Recently, a variety of growth factor-dependent subclones of the murine interleukin-3 (IL-3)-dependent cell line 32D have been isolated. These subclones include those dependent for growth on erythropoietin (Epo) (32D Epo), granulocyte-macrophage colony-stimulating factor (GM-CSF) (32D GM), or granulocyte colony-stimulating factor (G-CSF) (32D G). 32D Epol.l is a revertant of 32D Epo and is capable of growing in IL-3. These cell lines express the differentiation program appropriate to the specific growth factor and depend on the growth factors not only for proliferation but also for survival. To determine how the signal for proliferation is triggered by various growth factors, we examined the DNA histograms and the expression of cell cycle-specific genes in the different cell lines. The cell cyclespecific genes analyzed were myc (early G,), myb (late G,), and the structural genes for the calcium-binding protein 2A9 (middle G,) and histone H3 (G1-S boundary). The DNA histogram analysis of cells in the logarithmic phase of growth showed that approximately 40% of 32D. 32D GM, 32D G, and 32D Epol.l (growing in IL-3) were cells with a 2N DNA content (and therefore in Go/Gl), and another 40% have a DNA content intermediate between 2N and 4N (in S phase). In contrast, 32D Epo and 32D Epol.1 (growing in Epo) had fewer cells in the Go/G1 phase of the cell cycle compared with the number of cells that were in URING hematopoietic differentiation, multipotent D progenitor cells become restricted in the programs they can express. Central to the process is the interaction of specific hematopoietic growth factors with receptors on the surface of progenitor cells.' Some growth factors, such as interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF), act early, whereas others, such as granulocyte-CSF (G-CSF), macrophage-CSF (M-CSF), and erythropoietin (Epo), act later on cells already committed to a specific lineage.2 The combined process of hematopoietic differentiation requires 10 to 20 cell divisions. With each division, a cell becomes more and more restricted in its differentiation potential, less sensitive to early-acting growth factors, and more dependent on the presence of late-acting growth factors. Therefore, the control of the cell cycle must change with progressive cell divisions.
D progenitor cells become restricted in the programs they can express. Central to the process is the interaction of specific hematopoietic growth factors with receptors on the surface of progenitor cells.' Some growth factors, such as interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF), act early, whereas others, such as granulocyte-CSF (G-CSF), macrophage-CSF (M-CSF), and erythropoietin (Epo), act later on cells already committed to a specific lineage.2 The combined process of hematopoietic differentiation requires 10 to 20 cell divisions. With each division, a cell becomes more and more restricted in its differentiation potential, less sensitive to early-acting growth factors, and more dependent on the presence of late-acting growth factors. Therefore, the control of the cell cycle must change with progressive cell divisions.
It is difficult to use normal progenitor cells to study cell cycle control during differentiation. However, studies with growth factor-dependent cell lines have shown that the cell cycle sustained by Ep0'3~ or IL-35,6 is similar to that observed in normal fibroblasts or T cells7 in that the cells spend approximately 40% of their time in Go-GI phase, 40% in S phase, and the remaining 20% in G2 + M. Early information on the cell cycle progression of normal progenitor cells was obtained using the 3H-thymidine ('H-TdR) suicide technique. This technique measures the proportion of cells that are killed by short exposure to high specific activity 'H-TdR. Assuming that all the cells are in cell cycle, the proportion of cells killed depends on the length of S phase. Such studies showed that cells stimulated by IL-3, such as the erythroid burst-forming cells (BFU-E) or granulocyte-macrophage colony-forming cells (GM-CFC) have, at most, a suicide rate of Cells that proliferate in response to Epo, such as the erythroid colthe S phase (1 9% to 31 % v 69% to 78%, respectively). Because all the cell lines have comparable doubling times (1 5 to 1 8 hours), the cell distribution among the phases of the cell cycle is proportional to the length of the phase. Therefore, cells growing in IL-3 (32D and 32D Epol.1). GM-CSF (320 GM), or G-CSF (32D G) progress along the cycle in a manner typical of previously reported nontransformed cell lines. In contrast, cells growing in Epo (32D Epo or 32D Epol.l) spend relatively less time in Go/G1 and correspondingly more time in S. These data were confirmed by the analysis of the tritiated thymidine (3H-TdR) suicide rate and of the expression of cell cycle-specific genes. The 32D and 32D Epol.l cells growing in IL-3 had a suicide rateof ~5 0 % . whereas the suicide rate of 32D Epo and 32D Epol.1 growing in Epo was higher than 75%. All the cell lines expressed comparable levels of myc and myb, whereas 32D Epo expressed undetectable levels of 2A9 and increased levels of histone H3. These results indicate that cells may progress along the cell cycle according to different pathways depending on which growth factor triggers the process. The prolonged S phase induced by Epo and described here could provide a cellular mechanism for the high 3H-TdR suicide rate previously reported for normal murine and human Epo-dependent erythroid progenitors. ony-forming cell (CFU-E),8.9 have a suicide rate of 70% to 80%. The length of the S phase described for the IL-3-and Epo-dependent cell lines (-40% of cycle time) is consistent with the 'H-TdR suicide rate of 40% for BFU-E and GM-CFC but not with the 70% to 80% suicide rate reported for
We have established subclones of the murine cell line 32D that grow in Epo, GM-CSF, or G-CSF and differentiate along the erythroid, granulocyte-macrophage, or granulocyte pathway, respectively."." The 32D grows in IL-3 and differentiates into mast cells.12 Because all the cell lines have the same diploid genotype and do not induce tumors when injected into syngeneic recipients, they can be used as a model to CFU-E.
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SHIMADA ET AL study in the same genetic background proliferation and differentiation induced by the different hematopoietic growth factors. In this study we have used the cell lines to determine how different growth factors signal proliferation and how the cells respond.
The results indicate that although IL-3, GM-CSF, and G-CSF trigger similar proliferation progression, Epo sustains a "unique" progression characterized by a very short Go/GI phase and, consequently, a longer S phase. These data are consistent with the high 3H-TdR suicide rate previously observed for Epo-responsive hematopoietic cells839 and suggest that untransformed cells may choose between alternative cell cycle progressions, depending on the growth factor that triggers the proliferation event.
MATERIALS AND METHODS
The 32D c13 cell line12 and its Epo-, GM-CSF-, or G-CSF-dependent subcloneslO," were maintained by biweekly passage in McCoy's medium (GIBCO, Grand Island, NY) modified as de~cribed,'~ and supplemented with antibiotics, L-glutamine, and pyruvic acid (1% vol/vol; GIBCO), fetal bovine and horse serums (IO%, vol/vol of each; Hyclone Laboratories, Logan, UT), and the appropriate growth factor (described below). The 32D Epol. 1 is an IL-3-dependent revertant of 32D Epo, which can respond to either Epo or IL-3.14 All cell lines were periodically tested for the presence of mycoplasma contamination with Mycoplasma T.C.11 (Genprobe, San Diego, CA) and were found to be mycoplasma free.
Cell cycle analysis and measurement of 'H-TdR suicide rate. DNA histograms of cells in the logarithmic phase of growth were obtained by staining them with propidium iodide as de~cribed.'~.'~ The 3H-TdR suicide rate was measured by incubating at 37°C for 20 minutes 2 X IO5 32D, 32D Epol.1, or 32D Epo cells (growing in the appropriate growth factors), either in medium alone or in medium containing 5 to 10 pCi 3H-TdR (Amersham, Arlington Heights, IL; specific activity, -5 to 20 Ci/mmol) or 10 pCi of 3H-TdR plus 100 nmol of cold TdR (-100 X excess)." At the end of the incubation, the cells were extensively washed and the number of cells able to form colonies evaluated in semisolid culture as described."
RNA was prepared by phenolchloroform extraction of acid guanidinium thiocyanate lysates.'' RNA, dissolved in MOPS buffer (20 mmol/L MOPS, 5 mmol/L EDTA, 5 mmol/L sodium acetate, pH 7.0) containing 50% formamide and 1.9 mol/L formaldehyde, was heated at 65°C for 15 minutes, supplemented with 1 pg of ethidium bromide, and loaded onto a 1% agarose gel in MOPS buffer containing 0.66 mol/L formaldehyde. The gel was run at 30 V for 18 hours. After the gel was blotted to a nitrocellulose membrane, hybridization was performed in 4.7X SSPE, 50% formamide, 0.47X Denhardt, 10% dextran sulphate, 0.1% sodium dodecyl sulfate (SDS), 0.34% milk, and 180 pg/mL salmon sperm DNA at 42°C for 18 hours. After washing with 0.1 X SSC, 0.1% SDS at 50"C, the filters were hybridized with the probes described below that had been labeled to a specific activity of IO9 cpm/pg DNA with (aZZP) deoxycytidine triphosphate using a random oligonucleotide priming kit (Boehringer, Mannheim, Germany) as recommended by the manufacturer.
To identify kinases that could be selectively associated with the IL-3, GM-CSF, G-CSF, or Epo receptor, we analyzed by Northern analysis the expression in these cell lines of two classes of protein kinases: genes with homology with the src family of protein kinases, including lck, hck, fyn, lyn, fgr, fes," and srczo (provided by Dr Roger Perlmutter, University of Washington), and the serinethreonine kinase, pim-Iz1 (provided by Dr Anton Bems, Netherlands Cancer Institute). We also analyzed the expression of the oncogenes myc and myb (nuclear factors, provided by Dr Gianni Rovera, Wistar
Cell lines.
Northern analysis.
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Institute), histone H3 (H3),22323 2A924 (a gene coding for a calciumbinding protein), thymidine kinase (TK),25 and the d subunit of DNA polymerase (PCNA)26 (provided by Dr B. Calabretta, Thomas Jefferson University, Philadelphia, PA). As controls of mRNA loading, the gel was stained with ethidium bromide to determine the intensity of the ribosomal RNA, and the membrane was hybridized with a bovine @-actin probe. 27 Conditioned medium of phytohemagglutinin (PHAtstimulated LBRM 33 cells was prepared under serumdeprived conditions as described." The growth factors studied included pure recombinant murine IL-3 and murine GM-CSF (provided by J.J. Mermod; Glaxo, Basel, Switzerland), and pure recombinant human Epo and human G-CSF (Amgen, Thousand Oaks, CA). Unless otherwise stated, PHA-LBRM 33-conditioned medium was used at a concentration of 3% (vol/vol). The growth factors were used at concentrations of 10 U/mL for IL-3, 1 ng/mL for GM-CSF, IO3 U/mL for G-CSF, and 1 U/mL for Epo. The cell distribution among the phases of the cycle is proportional to the length of the phase. Because all the cell lines have comparable doubling times (15 to 18 hours)," we can deduce the relative length of the phases of the cycle in the different cell lines from the cellular distribution in the DNA histogram. The cells growing in IL-3, GM-CSF, or G-CSF showed a cell cycle phase distribution consistent with that described for other IL-3-dependent cell line^^.^ as well as for fibroblasts and T cells.' In contrast, 32D Epo cells spend relatively more time in S than in Go-GI .
Growth factors.

RESULTS
Cell
In subsequent experiments, we determined the effect of growth factor starvation and suboptimal IL-3 and Epo concentrations on the proliferation of 32D, 32D Epol.1, and 32D Epo cells. Within 3 hours, growth factor starvation induced the appearance of dead (trypan blue-positive) cells in the culture. The amount of mRNA per cell also decreased (from ~1 4 X pg/cell to 9.6 and 1.8 X &cell at 3 and 6 hours after growth factor had been withdrawn, respectively). Twenty-four hours after the withdrawal of growth factor, more than 50% of the cells in the culture were dead; the cells that were still alive contained a very low amount of mRNA (-0.3 X Fg/celI). After 24 hours ofgrowth factor starvation, a slight increase in the number of cells in the Go/ GI (from 55% to 70%) phase of the cycle was observed for 32D cells. The cellular distribution of 32D Epo and Epo 1.1 cells among the phases of the cell cycle did not change after growth factor starvation.
Suboptimal concentrations of IL-3 or Epo did not affect the length of the cycle or the distribution of the cells in the The 3H-TdR suicide rate was also measured in 32D cells (cloned in IL-3), in 32D Epo 1.1 (cloned in IL-3 or in Epo), and in 32D Epo (cloned in Epo). The results are presented in Table 2 . Whereas 32D and 32D Epol.1 (cloned in IL-3) had a 3H-TdR suicide rate of 46% to 57%, 32D Epo and 32D Epol.1 (cloned in Epo) had a 3H-TdR suicide rate of 76% to 99%.
Expression of cell cycle markers in the different clones of 320. To further compare the differences in cell cycle progression found with the DNA histogram, we performed Northern analysis to determine the expression of genes that are usually activated at specific stages of the cell cycle and that are considered cell cycle markers.
All the cell lines expressed myc and myb (Figs 2 and 3 and  Table 3 ) at reasonably comparable levels. The 32D Epo (Fig  4) and 32D Epol. 1 growing in Epo (not shown) did not express detectable levels of 2A9 but did express high levels of H3. These data indicate that very few 32D Epo cells are in middle G I , in agreement with the DNA histogram analysis. No changes were observed in the levels of 2A9 and H3 mRNA in cells starved for 24 hours of growth factor or growing at suboptimal growth factor concentrations (results not shown). TK and PCNA, genes usually expressed at very low levels, were not detected (data not shown).
As shown in Fig 2, lane 3 , and in Fig 4, lane 2 , the expression of the @-actin gene was lower in the 32D Epo cell line. This is likely because @-actin is also relatively cell cycle-dependent being more abundantly expressed in G I .'
Expression of protein kinases in the different subclones of 320. The IL-3, GM-CSF, G-CSF, and Epo receptors belong to the hematopoietic growth factor receptor superfamily. One of the peculiarities of this family of receptors is the lack of protein kinase domain(s) in the intracellular region. However, stimulation of responsive cell lines with these growth factors is followed by rapid (within 1 minute) phosphorylation of several different protein^.'^-^^ Therefore, it is postulated that protein kinases are closely associated in a receptor complex form with the receptors of this family.
In these experiments, the only tyrosine kinase detectable was the 3.0-kb transcript for lyn (Fig 5) . All the cell lines expressed detectable levels of pim-1 (Fig 2) . The level of expression of pim-1 varied greatly between the cell lines and was barely detectable in 32D (Fig 2, lane 1) . The highest levels of expression were observed in 32D Ro (a GM-CSFresponsive version of 32D with a mast cell phenotype34) (Fig  2, lane 2) and 32D GM (Fig 2, lane 6 ). This indicates that the expression of the pim-1 gene could be upregulated together with activation of the GM-CSF receptor.
DISCUSSION
Epo-dependent cell lines, such as DA-l3 and HCD-57,4 have been used to study the mechanisms by which Epo induces proliferation of erythroid cells. These cell lines require Epo to progress from the G , to the S phase of the cell cycle, the relative lengths of the phases being very similar to those observed in the IL-3-dependent cell lines C-63' and FDCP-1.6 However, the HCD-57 and DA-1 cell lines are transformed and differentiate very poorly in vitro.
We have used several growth factor-dependent cell lines to study the cell cycle progression induced by IL-3, GM-CSF, G-CSF, and Epo. With the appropriate target, IL-3, GM- CSF, and G-CSF induced a cell cycle progression similar to that described for the C-63 and FDCP-1 cell as analyzed by DNA histogram. In contrast, Epo induced a specific cell cycle progression characterized by a shorter GdG, phase of the cycle and by a correspondingly longer S phase. This Epo-induced cell cycle pattern is similar to the cell cycle progression observed for purified CFU-E in vitro35 and explains why CFU-E exhibit such a high 'H-TdR suicide
The DNA histogram analysis was confirmed by the analysis of the 'H-TdR suicide rate (Table 2 ) and of the expression of cell cycle-specific genes' ( Table 3) . Some of the genes investigated (myc and myb) are also proto-oncogenes involved in the control of hematopoietic cell proliferation. Myc is expressed specifically in early GI and is required for cells to enter S phase. In fact, progression of cells in S phase is induced in fibroblasts by activating ectopic myc expression36 and is inhibited in T cells by exposing them to myc antisense oligom e r~.~' Myb seems to be important in the proliferation of adult progenitors of all types because myb antisense oligomers pim-lmyc -I 2 3 4 5 6 inhibit the in vitro growth and differentiation of both adult erythroid bursts and GM c~l o n i e s ,~* *~~ and transgenic mice lacking this gene have impaired fetal-adult but normal embryonic hematopoiesis.40 Downmodulation of myb expression could be a prerequisite for both erythroid and myeloid differentiation because its expression decreases during these pro~esses~'.~* and its ectopic expression blocks the Epo-induced differentiation in an erythroleukemic cell line!3
All the cell lines studied here expressed reasonably comparable levels of myc and myb (Table 3) . We did not find the expected downregulation of myb expression in the 32D Epo and G cell lines. Such a downmodulation could have been masked by the different relative ratios between proliferating and differentiated cells in the cell populations investigated. --
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The levels of expression are given as a percent of the level of expression of @-actin. Because of the different exposure times and the different hybridization affinities of the probes, the results should be compared only within each probe. The exposure times were: actin, 2 hours; H3, 5 hours; myc. 2 days; lyn and pim-l,3 days; myb, 5 days; 2A9, 10 days.
Where numerical values are absent, the results were below detectable levels.
The pattern of progression through the cell cycle seems to be the result of stimulation with Epo and not an intrinsic property ofthe erythroid differentiation program. In fact, the IL-3-responsive revertant, 32D Epo I. I , growing in IL-3 progressed along the cycle in a fashion similar to the parent 32D cell line despite the fact that the cells maintained their erythroid phen~type.'~'" Therefore, the control of cell cycle progression induced by Epo occurs through a signal transduction pathway at least partially uncoupled from that of the differentiation program. A similar dissociation between induction of differentiation and induction of proliferation has been described for M-CSF in macrophage^^^ and may represent a general feature of late-acting hematopoietic growth factors.
Cell proliferation does not occur until the cells reach a critical size. Such an increase in cell mass occurs usually in G I . Because the total length of the cycle in 32D Epol . I did not change when the cells were stimulated with IL-3 or Epo, the functions that lead to increased cellular mass in these cells had to be completed in G I when the cells were growing in IL-3 or in S when the cells were stimulated by Epo. This aspect, as well as other aspects of cell cycle regulation, could be investigated further by synchronizing the cells in some fashion. We have tried to synchronize the cells by growth factor ~tarvation,5.~~ growing the cells in suboptimal growth factor concentrations, and size fractionation by cell sorting. In the absence of IL-3 or Epo, the cells seem to die, independent of the phase of the cycle in which they are, and the presence of suboptimal growth factor concentrations affects the maximal saturation density but not the progression along the cell cycle. Furthermore, we have also failed to synchronize the cells by size fractionation because these cells not only proliferate but also differentiate in culture. Therefore, size differences also reflect different stages of differentiation.
To characterize partially the signal transduction pathways that could differentiate cells growing in Epo from cells growing in IL-3, GM-CSF, or G-CSF, we analyzed the expression in these cell lines of protein kinases believed to be involved in signal transduction in hematopoiesis. We found that all the cell lines expressed the tyrosine kinase lyn and the serinethreonine kinase pim-I. These data are consistent with the recent studies of Yi et aI4' and Stanley et aI4* who have shown that lyn is expressed in normal cells derived from murine BFU-E and GM-CFC and in the FDCP-I cell line. Interestingly, the expression of pim-1 was increased in cells that had acquired the potential to respond to GM-CSF. This fact suggests that the regulation of the pim-l gene is coupled with the regulation of the GM-CSF receptor.
Immortalized fibroblasts infected and therefore transformed by adenovirus have a cell cycle progression similar to that described here for 32D Epo growing in Epo?' Until now, this pattern of cell cycle progression was interpreted to be a result of the transformation process and therefore of the altered proliferation control in these cells. Our data suggest that this cell cycle progression pattern represents an alternative proliferation pathway and that the cells switch the pathways , lanes 4 and 5) . 320 G growing in G-CSF (lane 6). and 32D GM growing in GM-CSF (lane 7) or 11-3 (lane 8).
used according to the growth factor that delivers the proliferation signal.
Until now, cell cycle progression has been mainly studied with cell cycle mutants in yeast.w Such studies have confirmed that cell cycle progression requires the interaction between two classes of proteins, cdc2 and cyclins. Recently, eukaryotic cdc2'' and cyclin" genes specific for the hematopoietic system have been cloned. Of the three cyclin genes cloned from a macrophage library, one is particularly involved in the in- For personal use only. on October 25, 2017. by guest www.bloodjournal.org From
